The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors / Q000032:analysis*; D002122:Calcium Chloride / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005169:Factor VIII / Q000032:analysis*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008722:Methods; D010974:Platelet Aggregation / Q000187:drug effects; D012310:Ristocetin / Q000032:analysis* / Q000494:pharmacology; D012965:Sodium Chloride / Q000008:administration & dosage; D013552:Swine; D014842:von Willebrand Diseases / Q000097:blood; D014841:von Willebrand Factor / Q000032:analysis* / Q000302:isolation & purification
D001779:Blood Coagulation Factors; D014841:von Willebrand Factor; D012310:Ristocetin; D012965:Sodium Chloride; D005169:Factor VIII; D002122:Calcium Chloride